IMMUNOLIGHT ILLUMINATION INNOVATION TRANSFORMATION

Serial Number 97773307
731

Registration Progress

Application Filed
Jan 30, 2023
Under Examination
Apr 16, 2024
Approved for Publication
Feb 2, 2024
Published for Opposition
Feb 20, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Oct 16, 2025 93 days

Trademark Image

IMMUNOLIGHT ILLUMINATION INNOVATION TRANSFORMATION

Basic Information

Serial Number
97773307
Filing Date
January 30, 2023
Published for Opposition
February 20, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
731
Status Date
May 1, 2025
Application
Pending
Classes
001 005

Rights Holder

Immunolight, LLC

16
Address
1901 St. Antoine Street, 6th Floor
Detroit, MI 48226

Ownership History

Immunolight, LLC

Original Applicant
16
Detroit, MI

Immunolight, LLC

Owner at Publication
16
Detroit, MI

Legal Representation

Attorney
James Derek Mason

USPTO Deadlines

Next Deadline
93 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
October 16, 2025
Extension Available
Until April 16, 2025

Application History

39 events
Date Code Type Description Documents
May 1, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 1, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 15, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 15, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 15, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 15, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 15, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 15, 2024 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Oct 15, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Oct 15, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 15, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 15, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 3, 2024 NOAC E CORRECTED NOA E-MAILED Loading...
May 2, 2024 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
May 2, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 17, 2024 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Apr 17, 2024 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Apr 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 17, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 4, 2024 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 4, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 4, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 20, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 19, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 19, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 30, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 30, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 30, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 26, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 17, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 16, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 2, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Chemically-based preparations and compounds for curing adhesives
Class 005
Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of autoimmune disease or disorders

Additional Information

Design Mark
The mark consists of three triskelion swirls left of the wording "IMMUNOLIGHT" which is above the wordng "ILLUMINATION INNOVATION TRANSFORMATION" separated by two vertical lines.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005